OTC · Financial Statements

Living Cell Technologies Limited (LVCLY) Financial Statements

$0.03 OTC: LVCLY Market Cap $11.39M

Living Cell Technologies Limited most recently reported annual revenue of $0, net profit of $-2.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.

Annual Financials (USD)

Metric20202021202220232024
Revenue$0$0$0$0$0
Operating Profit$-3.0M$-2.0M$-2.0M$-2.0M$-2.0M
Net Profit$-1.0M$-1.0M$-2.0M$-2.0M$-2.0M
EPS$-0.02$-0.02$-0.02$-0.02$-0.01
Op Margin-99304.0%-849.7%-69781.2%-5068.3%—

Balance Sheet (USD)

Metric20202021202220232024
Total Assets$3.0M$2.0M$4.0M$4.0M$3.0M
Total Liabilities$1.0M$0$0$0$0
Cash$3.0M$2.0M$4.0M$4.0M$3.0M
Borrowings$0$0$0$0$0

Cash Flow (USD)

Metric20202021202220232024
Operating Cash Flow$-3.0M$-1.0M$-2.0M$-2.0M$-2.0M
Investing Cash Flow$2.0M$0$0$0$0
Financing Cash Flow$0$0$5.0M$2.0M$1.0M
Net Cash Flow$-2.0M$-1.0M$3.0M$0$0
Free Cash Flow$-3.0M$-1.0M$-2.0M$-2.0M$-2.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-0.12
EV / EBITDA-13.57
FCF Yield-6.21%
Quick Ratio17.89
Interest Coverage0.00
Return 1Y—
Return 3Y—
Return 5Y—

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
LVCLY Overview LVCLY Dividend Run Stock Screener